Inhibitory effect of potassium citrate on rat renal tumors induced by N-ethyl-N-hydroxyethylnitrosamine followed by potassium dibasic phosphate. 1993

N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
Second Department of Pathology, Nara Medical University.

Potassium dibasic phosphate (PDP) was administered at a concentration of 10% by weight in basal diet to unilaterally nephrectomized Wistar rats previously given 1000 ppm N-ethyl-N-hydroxyethyl-nitrosamine (EHEN) in the diet for 2 weeks. To study the effect of alkalinization on renal mineralization, some animals concomitantly received 5% potassium citrate (PC). Feeding PDP alone promoted adenomatous hyperplasias, which were regarded as preneoplastic lesions, as well as renal cell tumors in EHEN-initiated rats, whereas the addition of PC to PDP diets reduced the promoting effect. Histopathology, serum biochemistry and urinalysis indicated retardation of renal calcium crystallization by PC. Two other phosphate salts, sodium phosphate (SP) and calcium phosphate (CP), were also administered. SP showed a slight promoting effect on adenomatous hyperplasias and a 2-fold increase in the yield of renal cell tumors, while CP induced a clear reduction of both lesions, over EHEN alone. The promoting effects of both PDP and SP and the inhibitory effect of PC were somewhat correlated to 5-bromo-2'-deoxyuridine labeling indices, the degree of nephropathy, and mineralization in the kidney. Immunohistochemically, the nephropathy induced by phosphate salts was not linked to alpha 2u-globulin. A pathogenesis for renal carcinogenesis is suggested in which nephropathy associated with mineralization enhances the development of renal cell tumors.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002951 Citrates Derivatives of CITRIC ACID.
D004052 Diethylnitrosamine A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. Nitrosodiethylamine,N-Nitrosodiethylamine,N Nitrosodiethylamine

Related Publications

N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
January 1995, Toxicologic pathology,
N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
January 2001, Toxicologic pathology,
N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
October 1983, Gan,
N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
December 1979, Gan,
N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
February 1999, Cancer letters,
N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
February 2001, Pathology international,
N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
October 2002, Cancer letters,
N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
October 1982, Journal of the National Cancer Institute,
N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
July 1984, Journal of the National Cancer Institute,
N Konishi, and K Nishii, and I Hayashi, and S Nakaoka, and K Matsumoto, and T Yabuno, and Y Kitahori, and Y Hiasa
April 1984, Cancer research,
Copied contents to your clipboard!